Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer
Clinical trial NCT04346914 · UNKNOWN
Trial details
- NCT number
- NCT04346914
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-08
- Primary completion
- 2022-10-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.